Clinical trials
Cutaneous Squamous Cell Carcinoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AdventHealth Translational Research Institute | 1 |
| Albert Einstein College of Medicine | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Elucid Labs Inc. | 1 |
| Henan Cancer Hospital | 1 |
| Indiana University | 1 |
| Jewish General Hospital | 1 |
| King's College London | 1 |
| Region Örebro County | 1 |
| Rigshospitalet, Denmark | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 13 |
| Basal Cell Carcinoma | 5 |
| Melanoma | 3 |
| Carcinoma, Squamous Cell | 2 |
| Skin Neoplasms | 2 |
| Carcinoma, Merkel Cell | 1 |
| Keratosis, Actinic | 1 |
| Margins of Excision | 1 |
| Sarcoma | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.